|

A2/4-1BBL melanoma vaccine Clinical Trials

1 actively recruiting trial

Also known as: M20/A2B vaccine

Pipeline

Phase 1/2: 1

Top Sponsors

  • Hadassah Medical Organization1

Indications

  • Malignant Melanoma1
  • Cancer1

Other1 trial

Modified Vaccine for High Risk or Low Residual Melanoma Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.